Segment 3 - Provider Buy-in and Clinical Pathway Development

Dr Yu said that it is crucial for providers' voices to be heard in pathway development.

Dr Yu said that it is crucial for providers’ voices to be heard in pathway development.

“If you’re going to be successful, you need to have buy-in. If you need to have buy-in, you need to have people believe that it’s a transparent process of pathways development that they respect and feel that they had a voice in,” he explained.

He detailed how a healthcare setting can also impact pathway development, and the role that published medical literature has on the real-world setting practice. The actual experience of implementing pathways and patient behavior need to be closely monitored. There should also be feedback loops that include physicians.

Dr Tischler agreed, saying that provider buy-in is necessary. He said that for authentic buy-in, one cannot force a caregiver to act or practice in a certain way.

Related Videos
Screenshot of Sancy Leachman, MD, PhD, smiling
Manmeet Ahluwalia, MD, MBA.
Nicolas Ferreyros, BA, managing director, The Community Oncology Alliance
Susan Sabo-Wagner, MSN, RN, OCN, Oncology Consultants
Jessica Allegretti, MD, MPH.
Screenshot of Eva Parker, MD, smiling at the camera
Samyukta Mullangi, MD, MBA.
Lee Norman, MD
Manmeet Ahluwalia, MD, MBA.
Jessica Allegretti, MD, MPH.
Related Content
© 2023 MJH Life Sciences
All rights reserved.